Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 1

Research Article

Identification and Analysis of Chemical Constituents and Rat Serum Metabolites in Lycopodium clavatum Using UPLC-Q-TOF/MS Combined with Multiple Data-Processing Approaches

Table 1

Identification of the components from Lycopodium clavatum in vitro.

NO.(min)Measured Mass ()Fragment ions ()FormulaError (ppm)Identification

13.8002278.1756260, 162, 13408β-hydroxylycoposerramine
24.1863266.2119248, 230, 2020.38aeacetylfawcettiine
34.6209292.1914274, 203, 1350.34palhinine A
44.6343273.1963243, 200, 1861.46obscurinene
54.9963296.185278, 260, 2344.054α,8β,12β-trihydroxylycopodine
65.1711274.1811231, 167, 1581.46lycojaponicumin C
75.2178262.1807234, 206, 1640lycopoclavamine A
85.2195260.1661246, 24, 2163.84huperzine E [4]
95.3981280.1912262, 244, 1630.366α,8β-dihydroxylycopodine or 4α,8β-dihydroxylycopodine
105.5543261.1966245, 202, 1880.38des-N-methyl-α-obscurine
115.8878275.2125244, 188, 1480.73α-obscurine
126.0787278.212260, 217, 1890(15R)-14,15-dihydroepilobscurinol
136.2025248.2016230, 145, 1050.81lycopodine
146.4302322.2037244, 216, 1765.98β-acetoxy-12β-hydroxy-lycopodine or 8β-acetoxy-11α-hydroxy-lycopodine or 8β-hydroxy-11α-acetoxy-lycopodine
156.4922246.1854218, 176, 1241.62anhydrolycodoline
166.5863264.1966228, 242, 1910.76lycodoline
176.7897308.2226248, 230, 1590α-lofoline
187.3916276.1962218, 166, 1500.72lycoflexine
197.8795366.2274348, 288, 2283.82acetyllycofawcine
208.2908350.2324290, 2302.28acetylfawcettiine
218.5172195.066167, 152, 1151.54ferulic acid
2210.2069505.3513487, 263, 1993.1716-oxolyclanitin
2311.0118489.3571471. 453, 3451.84japonicumin B or lycoclavanin
2412.1919473.362102,111,1672.323R,21α,24-trihydroxyserrat-14-en-
16-one
2512.6387475.377457, 410, 2373.58Lycoclaninol [4] or japonicumin A
2613.0973461.362443,441,1022.38lycojaponicuminol C
2714.2839445.3667279,427,3193.3726-nor-8-oxo-α-onocerin
2815.3438457.3664439,3973.93lycojaponicuminol A
2915.5437459.3828441,398,3972.183-epilycoclavanol or
3β,21β,24-3-trihydroxyserrat-14-ene or
3α,21β,24-4-trihydroxyserrat-14-ene
3016.1058603.4045116,132,1340.66lycojaponicuminol D

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.